The Infection and Pathogenicity of SARS-CoV-2 Variant B.1.351 in hACE2 Mice
- PMID: 34569016
- PMCID: PMC8475296
- DOI: 10.1007/s12250-021-00452-1
The Infection and Pathogenicity of SARS-CoV-2 Variant B.1.351 in hACE2 Mice
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment on
-
Detection of a SARS-CoV-2 variant of concern in South Africa.Nature. 2021 Apr;592(7854):438-443. doi: 10.1038/s41586-021-03402-9. Epub 2021 Mar 9. Nature. 2021. PMID: 33690265
References
-
- Li Q, Nie J, Wu J, Zhang L, Ding R, Wang H, Zhang Y, Li T, Liu S, Zhang M, Zhao C, Liu H, Nie L, Qin H, Wang M, Lu Q, Li X, Liu J, Liang H, Shi Y, Shen Y, Xie L, Zhang L, Qu X, Xu W, Huang W, Wang Y. SARS-CoV-2 501Y. V2 variants lack higher infectivity but do have immune escape. Cell. 2021;184:2362–2371.e2369. doi: 10.1016/j.cell.2021.02.042. - DOI - PMC - PubMed
-
- Lv Z, Deng YQ, Ye Q, Cao L, Sun CY, Fan C, Huang W, Sun S, Sun Y, Zhu L, Chen Q, Wang N, Nie J, Cui Z, Zhu D, Shaw N, Li XF, Li Q, Xie L, Wang Y, Rao Z, Qin CF, Wang X. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020;369:1505–1509. doi: 10.1126/science.abc5881. - DOI - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
